| Cat. No. |
Size |
Price |
Figures |
|---|
RP10610-1 mg
| 1 mg | $ 104.50 | HPLC: 20060721145618 (PDF)
MS: 20060721145557 (PDF)
MSDS: 20050919140132 (PDF)
COA: 20080229021305 (PDF)
EXAMPLE:
Zoom
References:
- Renz H, et al. Comparison of the allergenicity of ovalbumin and ovalbumin peptide 323-339. Differential expansion of V beta-expressing T cell populations. J. Immunol. Dec 1993; 151(12): 7206-7213.
- Fukushima A, et al. Characterization of the immunopathogenic responses to ovalbumin peptide 323-339 in experimental immune-mediated blepharoconjunctivitis in Lewis rats. Curr. Eye. Res. Aug 1998; 17(8): 763-769.
- Oran, A. and H. Robinson, J. Immunol. 171, 1999 (2003)
|
|---|
RP10610-5 mg
| 5 mg | $ 418.00 |
|---|
| Full Name | |
| Alias |
OVA |
Sequence
(one-letter code) |
ISQAVHAAHAEINEAGR | Sequence
(three-letter code) | {ILE}{SER}{GLN}{ALA}{VAL}{HIS}{ALA}{ALA}{HIS}{ALA}
{GLU}{ILE}{ASN}{GLU}{ALA}{GLY}{ARG} |
|---|
| Description | OVA peptide 323-339 represents a T and B cell epitope of OVA, which is important in the generation and development of immediate hypersensitivity responses in BALB/c mice. Daily aerosolization of OVA 323-339 for 20 minutes over a period of 10 days has been as effective in the stimulation of a serum anti-OVA IgE antibody response as sensitization to native OVA by the same route. After sensitization to native OVA, the majority of the IgE anti-OVA response is directed against OVA peptide 323-339.
|
|---|
| Solubility | Soluble in water |
|---|
| Formula | C74H120N26O25 |
|---|
| M.W. | 1772.94 |
|---|
| Purity | 95% |
|---|
| Storage | Store at -20°C. |
| * For Non-Clinical Research Use Only * If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance. |
|
